Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1984 Dec;53(4):819–825.

Adoptive transfer of acquired resistance to Mycobacterium kansasii by T cells harvested from chronically-infected mice.

K P Hepper, F M Collins
PMCID: PMC1454875  PMID: 6334021

Abstract

Growth of Mycobacterium kansasii in intravenously infected mice ceases when the spleen cells express an enhanced non-specific resistance to a secondary challenge. Mice inoculated with 10(6) CFU M. kanasii 1203 develop a population of splenic T cells which are able to transfer protection passively to sublethally-irradiated syngeneic recipients when challenged with M. kansasii. Although the T-cell activated macrophages were unable to eliminate the mycobacteria from the spleen, they were able to prevent further growth of the organism in vivo. When mice which lack T cells (congenitally athymic, or 'nude' mice) were infected with M. kansasii, the cellular defences were unable to halt the progressive growth of the challenge organisms within the tissues. When normal mice were inoculated with large numbers of viable M. kansasii 1203 (up to 5 X 10(7) CFU), the activated macrophages within the spleen were capable of limiting the further growth of the bacterial population in vivo, but with no T-cell response capable of adoptively immunizing naive recipients against a secondary M. kansasii challenge. Thus, it seems likely that M. kansasii can induce the formation of activated macrophages by two separate mechanisms: one is a T-cell dependent process which occurs in mice inoculated with moderate doses (10(6) CFU) of M. kansasii, while the other is T-cell independent and occurs when a large infectious inoculum is employed.

Full text

PDF
819

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C. Mechanisms by which activated macrophages inhibit lymphocyte responses. Immunol Rev. 1978;40:3–27. doi: 10.1111/j.1600-065x.1978.tb00399.x. [DOI] [PubMed] [Google Scholar]
  2. Collins F. M., Cunningham D. S. Systemic Mycobacterium kansasii infection and regulation of the alloantigenic response. Infect Immun. 1981 May;32(2):614–624. doi: 10.1128/iai.32.2.614-624.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Collins F. M., Wayne L. G., v Montalbine The effect of cultural conditions on the distribution of Mycobacterium tuberculosis in the spleens and lungs of specific pathogen-free mice. Am Rev Respir Dis. 1974 Aug;110(2):147–156. doi: 10.1164/arrd.1974.110.2.147. [DOI] [PubMed] [Google Scholar]
  4. Cunningham D. S., Collins F. M. Suppressor and helper T-cell populations in Mycobacterium kansasii-infected spleens. Immunology. 1981 Nov;44(3):473–480. [PMC free article] [PubMed] [Google Scholar]
  5. Hepper K. P., Collins F. M. Immune responsiveness in mice heavily infected with Mycobacterium kansasii. Immunology. 1984 Oct;53(2):357–364. [PMC free article] [PubMed] [Google Scholar]
  6. Lane F. C., Unanue E. R. Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med. 1972 May 1;135(5):1104–1112. doi: 10.1084/jem.135.5.1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ledbetter J. A., Herzenberg L. A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 1979;47:63–90. doi: 10.1111/j.1600-065x.1979.tb00289.x. [DOI] [PubMed] [Google Scholar]
  8. Lefford M. J. Transfer of adoptive immunity to tuberculosis in mice. Infect Immun. 1975 Jun;11(6):1174–1181. doi: 10.1128/iai.11.6.1174-1181.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mage M. G., McHugh L. L., Rothstein T. L. Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J Immunol Methods. 1977;15(1):47–56. doi: 10.1016/0022-1759(77)90016-3. [DOI] [PubMed] [Google Scholar]
  11. Newborg M. F., North R. J. Generation of enhanced macrophage-mediated antibacterial resistance in animals responding to tumor allografts. Infect Immun. 1982 Jan;35(1):143–150. doi: 10.1128/iai.35.1.143-150.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. North R. J., Mackaness G. B., Elliott R. W. The histogenesis of immunologically committed lymphocytes. Cell Immunol. 1972 Apr;3(4):680–694. doi: 10.1016/0008-8749(72)90130-x. [DOI] [PubMed] [Google Scholar]
  13. North R. J. The action of cortisone acetate on cell-mediated immunity to infection: histogenesis of the lymphoid cell response and selective elimination of committed lymphocytes. Cell Immunol. 1972 Mar;3(3):501–515. doi: 10.1016/0008-8749(72)90255-9. [DOI] [PubMed] [Google Scholar]
  14. Orme I. M., Collins F. M. Resistance of various strains of mycobacteria to killing by activated macrophages in vivo. J Immunol. 1983 Sep;131(3):1452–1454. [PubMed] [Google Scholar]
  15. Volkman A., Collins F. M. The restorative effect of peritoneal macrophages on delayed hypersensitivity following ionizing radiation. Cell Immunol. 1971 Dec;2(6):552–566. doi: 10.1016/0008-8749(71)90004-9. [DOI] [PubMed] [Google Scholar]
  16. Zinkernagel R. M., Blanden R. V., Langman R. E. Early appearance of sensitized lymphocytes in mice infected with Listeria monocytogenes. J Immunol. 1974 Feb;112(2):496–501. [PubMed] [Google Scholar]
  17. Zinkernagel R. M., Blanden R. V. Macrophage activation in mice lacking thymus-derived (T) cells. Experientia. 1975 May 15;31(5):591–593. doi: 10.1007/BF01932477. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES